[1] |
BIAN Weigang, CHEN Ping, ZHOU Xiaoning, CHEN Haiting, SONG Shu.
LncRNA SNHG1 targets miR-101-3p to regulate oxaliplatin resistance in gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 242-247.
|
[2] |
HAN Zhongcheng, MA Lili, CUI Zhiwen, FENG Yanyan, WANG Fang.
Efficacy of first-line SOX chemotherapy plus Apatinib for advanced gastric cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(1): 62-67.
|
[3] |
GAN Shenghong, KE Zewen, LI Yong.
Meta-analysis of immune-enhanced enteral nutrition on immune function after radical gastrectomy in Chinese
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(1): 68-75.
|
[4] |
Wang Ying,Duan Heli.
Analysis of the pathological features and prognostic of patients with gastric carcinoma and thrombocytosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(1): 42-46.
|
[5] |
Yang Liuting,Jiang Penglei,Zu Dandan,Li Meining,Zhang Dong,Chang Bingmei.
Effect of NK4 gene expression combined with oxaliplatin on apoptosis and invasion by human colorectal cancer HCT116 cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(6): 456-461.
|
[6] |
Long Pengchen,Huang Mingwei,Wu Liucheng,Chen Jiansi.
The effect of neoadjuvant chemotherapy on advanced gastric cancer surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(6): 473-477.
|
[7] |
Gao Nana,Ma Xin,He Xin'ai.
Efficacy of celecoxib combined with chemotherapy in the treatment of advanced gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(6): 478-481.
|
[8] |
Zhou Xiao,Huang Tingting,Qiu Hong.
Expression of FGFR2,THBS1 and THBS4 and correlation with gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(5): 368-372.
|
[9] |
Yin zhenzhen,Wang Xiaoyan,Jiang Xiangjun.
Relationship between IL-17 gene polymorphism and gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(1): 50-54.
|
[10] |
Huang Mingwei,Wu Liucheng,Qin Yuzhou,Li Zhao,Zhang Meng,Su Di,Chen Jiansi.
Expression and clinical significance of both hypoxia-inducible factor(HIF)-1α and CD44 in gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 360-364.
|
[11] |
Yin Haiqing,Gao Shoubao,Shan Huiguo,Duan Xueyu.
Efficacy and safety of capecitabine maintenance therapy for patients with advanced gastric cancer after first-line XELOX chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(5): 291-294.
|
[12] |
He Ying,Wei Minglang,Wang Daiyou.
The clinical comparative observation of preoperative induction chemotherapy with TOF or TPF regimen for advanced oral squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(3): 161-164.
|
[13] |
Shao Peng,Yu Xinlin,Hu Wei,Li Yuechun,Wang Junchen,Wen Zhizhen.
Clinical observations of S-1 combined with transarterial infusion with oxaliplatin and em-bolism to treat advanced gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(2): 96-99.
|
[14] |
YANG Xi-hua,JIN Qin-wen,WANG Li,CHEN Jian-si.
Therapeutic efficacy of neoadjuvant chemotherapy for potentially resectable gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(4): 324-327.
|
[15] |
CHEN Dan,CHEN Li-jun.
Analysis of health behavior self-efficacy in gastrointestinal cancer patients and factors that influence it
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(2): 164-168.
|